Triarylpyrazole Derivatives as Potent Cytotoxic Agents; Synthesis and Bioactivity Evaluation “Pyrazole Derivatives as Anticancer Agent”
作者:Bilqees Sameem、Ebrahim Saeedian Moghadam、Majid Darabi、Zahra Shahsavari、Mohsen Amini
DOI:10.1055/a-1498-1714
日期:2021.9
several anti-cancer agents were introduced for the treatment of diverse kinds of cancer. Despite their potential in the treatment of cancer, drug resistance and adverse toxicity such as peripheral neuropathy are some of the negative criteria of anti-cancer agents and for this reason, the design and synthesis of new anti-cancer agents are important. Objective Design, synthesis, and anticancer activity
背景在最近几年中,引入了几种抗癌剂来治疗多种癌症。尽管它们在治疗癌症方面具有潜力,但耐药性和诸如周围神经病变等不良毒性是抗癌剂的一些负面标准,因此,新抗癌剂的设计和合成很重要。目的部分吡唑衍生物的设计、合成及抗癌活性评价。方法采用多步合成方法制备一系列目标化合物。它们对三种不同的人类癌细胞系即人类结肠癌细胞 (HT-29)、上皮癌细胞 (U-87MG)、胰腺癌细胞 (Panc-1) 以及 AGO1522 正常细胞系的细胞毒活性在体外使用 3- (4,5-二甲基噻唑-2-基)-2, 研究了 5-二苯基溴化四唑 (MTT) 测定。结果 1,3-Diaryl-5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-1H-pyrazole 和 1,3-Diaryl-5-(3,4,5-trimethoxyphenyl)-1H-pyrazole以良好的收率合成,并使用 1H-NMR、13C-NMR